← Browse by Condition
Medical Condition

pancreatic adenocarcinoma metastatic

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1
NCT07377045 Phase 1
Recruiting

Clinical Trial of OMTX705 in Combination With Gemcitabine/Nab-Paclitaxel and Tislelizumab in Patients With Advanced/Metastatic Pancreatic Adenocarcinoma

Enrollment
69 pts
Location
United States, Spain
Sponsor
Oncomatryx Biopharma S.L.
View Trial →